Dual G9A/EZH2 Inhibition Stimulates Antitumor Immune Response in Ovarian High-Grade Serous Carcinoma. (2022)
Attributed to:
FUNCTION THROUGH CHIRALITY IN ORGANIC ELECTRONIC MATERIALS AND DEVICES
funded by
EPSRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1158/1535-7163.mct-21-0743
PubMed Identifier: 35131874
Publication URI: http://europepmc.org/abstract/MED/35131874
Type: Journal Article/Review
Volume: 21
Parent Publication: Molecular cancer therapeutics
Issue: 4
ISSN: 1535-7163